Bayer Hurts from Generic Competition & Pipeline Setbacks

We issued an update report on Bayer AG BAYRY on Nov 22, 2018.

It is a life science company with core competencies in the areas of health care and agriculture.

Several pipeline and regulatory updates are expected from the company in the coming quarters.Any adverse pipeline related news can impact the stock unfavorably.